Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AGR3 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.009 |
mRNA | CCDC6 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.009 |
mRNA | CHFR | CTRPv2 | pan-cancer | AAC | -0.092 | 0.009 |
mRNA | HMGB1 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.009 |
mRNA | CDC5L | CTRPv2 | pan-cancer | AAC | 0.092 | 0.009 |
mRNA | NHSL1 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.009 |
mRNA | MIER2 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.009 |
mRNA | DMTF1 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.009 |
mRNA | SLC25A37 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.009 |
mRNA | CDT1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |